Current Treatment Options in Neurology

, Volume 7, Issue 5, pp 413–417 | Cite as

Psychiatric manifestations of autoimmune disorders

  • David B. Weiss
  • Jarl Dyrud
  • Robert M. House
  • Thomas P. Beresford

Opinion statement

Psychiatric symptoms are common to many autoimmune disorders. Patients often will have mood disorders, anxiety, cognitive deficits, delirium, and psychosis. These symptoms may reflect the direct or indirect effect of the autoimmune disorder on the central nervous system, may be related to medications used to treat the disorder, or may be a direct psychologic impact from suffering with the autoimmune disorder. Accurately recognizing the psychiatric component and generating a differential diagnosis is a complex task for the treating physician. Treatment of the psychiatric component to the disorder often will include addressing steroid induced side effects, psychotropic medications, psychotherapy, patient and family education, and a strong physician-patient relationship.


Multiple Sclerosis Systemic Lupus Erythematosus Sarcoidosis Mood Disorder Scleroderma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Ciccarelli O, Werring DJ, Barker GJ, et al.: A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging-evidence of Wallerian degeneration. J Neurol 2003, 250:287–292.PubMedCrossRefGoogle Scholar
  2. 2.
    Miller DH, Barkhof F, Frank JA, et al.: Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002, 125:1676–1695.PubMedCrossRefGoogle Scholar
  3. 3.
    Rieckmann P, Maurer M: Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis. Curr Opin Neurol 2002, 15:361–370.PubMedCrossRefGoogle Scholar
  4. 4.
    Sadovnick AD, Remick RA, Allen J, et al.: Depression and multiple sclerosis. Neurology 1996, 46:628–632. This is a very good overview on an important topic.PubMedGoogle Scholar
  5. 5.
    Patten SB, Beck CA, Williams JVA, et al.: Major depression in multiple sclerosis, a population-based perspective. Neurology 2003, 61:1524–1527. This is a well-written article and good referencePubMedGoogle Scholar
  6. 6.
    Diaz-Olavarrieta C, Cummings JL, Velazques J, et al.: Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999, 11:51–57. This is a thorough overview of the subject.PubMedGoogle Scholar
  7. 7.
    Feinstein A: An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002, 59:674–678. This is a detailed examination of this topic.PubMedGoogle Scholar
  8. 8.
    Pujol J, Bello J, Deus J, et al.: Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997, 49:1105–1110.PubMedGoogle Scholar
  9. 9.
    Fassbender K, Schmidt R, Mossner R, et al.: Mood disorders and dysfunction of the hypothalamicpituitary-adrenal axis in multiple sclerosis. Arch Neurol 1998, 55:66–72.PubMedCrossRefGoogle Scholar
  10. 10.
    Feinstein A, Roy P, Lobaugh N, et al.: Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004, 62:586–590.PubMedGoogle Scholar
  11. 11.
    Benedict RHB, Weinstock-Guttman B, Fishman I, et al.: Prediction of neuropsychological impairment in multiple sclerosis. Arch Neurol 2004, 61:226–230.PubMedCrossRefGoogle Scholar
  12. 12.
    Mohr D, Goodkin DE, Bacchetti P, et al.: Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 2002, 55:55–61.Google Scholar
  13. 13.
    Amato MP, Ponziani G, Siracusa G, Sorbi S: Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 2001, 58:1602–1606.PubMedCrossRefGoogle Scholar
  14. 14.
    Tan EM, Cohen AS, Fries JF, et al.: The 1982 revised criteria for the classification of systemic lupus erythematosis. Arthritis Rheumatism 1997, 40:1725.Google Scholar
  15. 15.
    Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.PubMedCrossRefGoogle Scholar
  16. 16.
    Mok CC, Lau KS, Wong RWS: Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001, 28:766–771.PubMedGoogle Scholar
  17. 17.
    Brey RL, Holliday SL, Saklad AR, et al.: Neuropsychiatric syndromes in lupus. Neurology 2002, 58:1214–1220. This is a very good overview of the subject.PubMedGoogle Scholar
  18. 18.
    Belin C, Moroni C, Caillat-Vigneron N, et al.: Central nervous system involvement in Sjogren’s syndrome: evidence from neuropsychological testing and HMPAO-SPECT. Ann Med Intern 1999, 150:598–604.Google Scholar
  19. 19.
    Brito GN, Araujo GR, Papi JA: Neuropsychological, neuroimage and psychiatric aspects of primary Sjogren’s syndrome. Arq Neuropsiquiatr 2002, 60:28–31.PubMedGoogle Scholar
  20. 20.
    Valtysdottir ST, Gudbjornsson B, Lindqvist U, et al.: Anxiety and depression in patients with primary Sjogren’s syndrome. J Rheumatol 2000, 27:165–169. This article addresses an important topic.PubMedGoogle Scholar
  21. 21.
    Valtysdottir ST, Gudbjornsson B, Hallgren R, Hetta J: Psychological well-being in patients with primary Sjogren’s syndrome. Clin Exp Rheumatol 2000, 18:597–600.PubMedGoogle Scholar
  22. 22.
    Mauch E, Volk C, Kratzsch G, et al.: Neurological and neuropsychiatric dysfunction in primary Sjogren’s syndrome. Acta Neurol Scand 1994, 89:31–35. A good overview on the topic.PubMedCrossRefGoogle Scholar
  23. 23.
    Inafuku T, Watanbe M, Takagi M, et al.: Giant cell arteritis with bilateral obstruction of the internal carotid artery - report of an autopsy case. Rinsho Shinkeigaku Clin Neurol 1998, 38:323–328.Google Scholar
  24. 24.
    Granel B, Gaudy C, Serratrice J, et al.: Psychological and behavioral disorders with good outcome in neurosarcoidosis. Rev Med Intern 2001, 22:183–188.CrossRefGoogle Scholar
  25. 25.
    Chang B, Steimel J, Moller DR, et al.: Depression in sarcoidosis. Am J Resp Crit Care Med 2001, 163:329–334. A complete overview on an important topic for clinicians.PubMedGoogle Scholar
  26. 26.
    Wirnsberger RM, de Vries J, Breteler MH, et al.: Evaluation of quality of life in sarcoidosis patients. Resp Med 1998, 92:750–756.CrossRefGoogle Scholar
  27. 27.
    Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, et al.: The impact of pain and symptoms of depression in scleroderma. Pain 2002, 95:267–275.PubMedCrossRefGoogle Scholar
  28. 28.
    Roca RP, Wigley FM, White B: Depressive symptoms associated with scleroderma. Arthritis Rheum 1996, 39:1035–1040.PubMedCrossRefGoogle Scholar
  29. 29.
    Angelopoulos NV, Drosos AA, Moutsopoulos HM: Psychiatric symptoms associated with scleroderma. Psychother Psychosom 2001, 70:145–150.PubMedCrossRefGoogle Scholar
  30. 30.
    Cutolo M, Nobili F, Sulli A, et al.: Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology 2000, 39:1366–1373.PubMedCrossRefGoogle Scholar
  31. 31.
    Zetting G, Asenbaum S, Fueger BJ, et al.: Increased prevalence of subclinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto’s encephalitis? Clin Endocrinol 2003, 59:643–647.Google Scholar
  32. 32.
    Chong JY, Rowland LP, Utiger RD: Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003, 60:164–171.PubMedCrossRefGoogle Scholar
  33. 33.
    Teuber I, Volz HP: Acute schizophreniform disorder in Hashimoto disease. Psychiatr Praxis 2003, 30(Suppl 2):S83-S84.Google Scholar
  34. 34.
    Lishman WA: Organic Psychiatary: The Psychological Consequences of Cerebral Disorder, Third Edition. Oxford: Blackwell Scientific Publications; 1997:709–714.Google Scholar
  35. 35.
    Paul RH, Cohen RA, Gilchrist JM: Ratings of subjective mental fatigue relate to cognitive performance in patients with myasthenia gravis. J Clin Neurosci 2002, 9:243–246.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • David B. Weiss
    • 1
  • Jarl Dyrud
  • Robert M. House
  • Thomas P. Beresford
  1. 1.Department of Behavioral HealthDenver Health Medical CenterDenverUSA

Personalised recommendations